Idexx Laboratories Inc (IDXX)

Sector: Healthcare
Industry: In Vitro & In Vivo Diagnostic Substances
Country: United States
Exchange: NASDAQ
Market cap: $54.33B
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
Latest financial period: September 30, 2026
Filed with the SEC: November 2, 2026
Estimated earnings date: Not available
Profit #41 of 1421 companies
| | Sep 26 | Jun 26 | Mar 26 | Dec 25 |
|---|
| ROIC | 59.3% | 60.4% | 56.5% | 54.6% |
Growth #416 of 1421 companies
Payout #475 of 1421 companies
Safety #247 of 1421 companies
Price #1140 of 1421 companies